门脉高压

提示抑制NOS活性和NO生成是汉防己甲素防治肝硬化门脉高压症的主要作用机理。

The vitally preventing mechanism of cirrhosis and portal hypertension is inhibiting the enzymatic activity of NOS.

目的：探讨门脉高压性胃病（PortalhypertensiongastropathyPHG）的病理特点，分析对PHG的影响因素。

Objective : To explore the pathological characters of Portal hypertension gastropathy ( PHG ), and to analysis the affecting factors of PHG .

肝硬化门脉高压腹膜后静脉曲张CT表现

CT characteristics of retroperitoneal varices in liver cirrhosis with portal hypertension

门脉高压脐静脉再通及其螺旋CT血管成像

Spiral CT Angiography of Patent Umbilical Vein in Portal Hypertension

门脉高压大鼠胃粘膜前列腺素E2含量的放免法测定

Radioimmunoassay of gastric mucosal prostaglandin e_2 in portal hypertensive rats with cirrhosis

门脉高压症静脉曲张的CT诊断

CT diagnosis of portal hypertension and varices

蛋白激酶Cα在门脉高压患者肝内外血管的表达

The Expression of PKC α in Spleen Artery and Vein and Intrahepatic Vessels of Patients with Portal Hypertension

血管紧张素II受体阻滞剂治疗肝硬化门脉高压的研究

Study of angiotensin II receptor blocker in treating cirrhosis patients with portal hypertension

门脉高压性胃病与HBV感染关系的免疫组化研究

Immunohistochemistry study on the relationship between portal hypertension gastrosia and HBV infection

电子束CT血管造影在肝硬化门脉高压的诊断和临床应用

The diagnosis and clinical application of electron beam CT angiography ( EBCT ) for portal hypertension in liver cirrhosis

Ⅰ、Ⅲ型前胶原mRNA在门脉高压症病人脾静脉壁的表达及意义

The expression of Type ⅰ and Type ⅲ procollagen mRNA in splenic vein of portal hypertensive patient

经颈静脉途径肝内门体分流术（TIPS）治疗门脉高压食管静脉血张出血的临床评估

Clinical evaluation of trans-jugular intrahepatic portosystemic shunt ( TIPs ) inpatients with portal

结论：NO，AgⅡ的变化在肝硬化门脉高压症的形成过程中起着重要作用；

CONCLUSION : Serum NO and Ag ⅱ play important roles in cirrhotic patients with portal hypertension .

应用TH胶行胃冠状静脉栓塞治疗门脉高压症的临床疗效分析

Clinical analysis of gastric coronary vein embolization with medical TH tissue adhesive for the treatment of portal hypertention

目的：通过核磁共振成像（MRI）的特殊序列和检查方法，评价MRI在肝硬化和门脉高压早期诊断中的作用。

Objective : To evaluate the diagnostic value of the special sequences and methods of MRI in liver cirrhosis and portal hypertension .

结论：利用MRI的特殊序列和检查方法在肝硬化和门脉高压早期诊断中有重要价值。

Conclusion : MRI special sequences and methods play a significant role in the early diagnosis of liver cirrhosis and portal hypertension .

K~+通道在门脉高压鼠动脉NE低反应中的作用

The Effect of Potassium Channels on Reduced Vascular Responsiveness to Norepinephrine in Portal Hypertensive Rats

背景：特发性门脉高压症（idiopathicportalhypertension，IPH）是病因不明的疾病，其主要临床特点为：明显的脾大伴有（或无）脾亢、贫血、消化道出血和门脉高压。

Background : Idiopathic portal hypertension ( IPH ) is a disease of unknown etiology .

结果：肝硬化门脉高压症大鼠血浆TNFα水平较正常对照组有明显增高（P<0.01）；

Results : PHT TNF α levels in venous plasma were significantly higher than NCG group ( P < 0.01 ) .

门脉高压病患者血清中TNF、ET的浓度变化与PHG的发生、发展呈正相关；

Concentration change of serum TNF and ET is associated with the development of PHG .

本院自1993年11月至1994年4月用经颈静脉肝内门体分流术（TIPS）收治肝硬化门脉高压患者5例。

Transjugular intrahepatic portosystemic shunts ( TIPS ) were done on 5 patients between November 1993 and April 1994 for treatment of variceal bleeding .

门脉高压症模型及TH胶栓塞胃食管曲张静脉的实验研究

A Model of Portal Hypertension on Rabbits and Experimental Studies of Embolism in the Submucous Varicose Veins of Both Esophagus Stomach With Colloidal Solution of TH

肝细胞型腺癌患者合并门脉高压、肝外转移的比率较大，HBsAg阳性率较高，供血较丰富。

Patients who are liver cell adenocarcinomas are easily with portal hypertension , extrahepatic metastases , positive HBsAg and rich supply of blood .

结果：门脉高压组较正常组腹壁下静脉内径明显增宽，腹壁下动脉RI减低。

Results : The diameter of inferior epigastric vein was found obviously wider , and RI in inferior epigastric artery decreased .

ET1对肝硬化门脉高压的作用及CNP、丹参对ET1介导肝星状细胞收缩的调控机制

Effects of ET-1 on Portal Hypertension in Hepatic Cirrhosis and the Mechanism of CNP 、 Radix Salviae Miltiorrhizae on ET-1-Mediated Contraction of HSCs

肝硬化门脉高压大鼠肺脏HO-1表达增加是实验性肝肺综合征发病的一个重要原因。

Increased pulmonary heme oxygenase-1 expression is an important contributor to the development of experimental hepatopulmonary syndrome .

在肝硬化门脉高压阶段，HO-1在各脏器表达不同，具有组织差异性。

In the stage of portal hypertension , the expressions of HO-1 are different in different tissues .

原发性肝癌伴门脉高压的TIPSS治疗

Primary Hepatocellular carcinoma with Portal Hypertension Treated with TIPSS

TIPSS治疗门脉高压症的护理

Nursing care for patients with portal hypertension after transjugular intrahepatic portosystemic stent shunt

研究背景门脉高压症（Portalhypertension，PHT）在当前仍然是我国较常见的一种临床综合征，其发病率较高，较难处理且病死率较高[1]。

Background : Portal hypertension ( PHT ) is still a more common and difficult clinic syndrome . It has a high incidence rate and mortality rate .